Trinity Biotech plc (TRIB) ADR Each Representing 20 Ord Shares SPON
$0.31
(15.50%)
- Add to watchlist
- This stock can be held in a
$0.31
(15.50%)
$0.31
(15.50%)
Business summary
Trinity Biotech plc is an Ireland-based commercial stage biotechnology company. The Company is focused on human diagnostics and diabetes management solutions, including wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market and has also entered the wearable biosensor industry. It intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Its products are used to detect infectious diseases and to quantify the level of Hemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. The Company sells direct in the United States and through a network of international distributors and strategic partners in over 75 countries worldwide.
Contact details
Important dates
General stock information
- Short code:
- TRIB
- ISIN:
- US8964385046
- Market cap:
- $22.74 million
- Shares in issue:
- 30.57 million
- Sector:
- Health Care Equipment
- Exchange:
- NASDAQ
- Country:
- United States
- Currency:
- US dollar
- Indices:
- NASDAQ Comb. Composite
Key personnel
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.